Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology

Published:2015-12-31 Issue:2 Volume:9 Page:141-151
ISSN:1756-2848
Container-title:Therapeutic Advances in Gastroenterology
language:en
Short-container-title:Therap Adv Gastroenterol

Author:

Abrams Matthew J.¹,Rakszawski Kevin²,Vasekar Monali²,Passero Frank¹,Abbas Atif³,Jia Yuxia²,Saif Muhammad Wasif⁴

Affiliation:

1. Tufts University School of Medicine, Boston, MA, USA

2. Penn State Hershey Medical Center, Hershey, PA, USA

3. EMD Serono Inc., Rockland, MA, USA

4. Director, GI Cancers and Leader of Experimental Therapeutics, Tufts University School of Medicine, 800 Washington Street, Boston, MA 02111, USA

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/1756283X15622601

Reference48 articles.

1. American Cancer Society (2015) Cancer Facts and Figures.

2. A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.

3. Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704

4. Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

5. Gemcitabine versus FOLFIRINOX in patients with advanced hENT1^+ve pancreatic adenocarcinoma.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model;PLOS Computational Biology;2023-01-17

2. Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model;2022-04-19

3. KRas4BG12C/D/PDE6δ Heterodimeric Molecular Complex: A Target Molecular Multicomplex for the Identification and Evaluation of Nontoxic Pharmacological Compounds for the Treatment of Pancreatic Cancer;Challenges in Pancreatic Cancer;2021-12-22

4. Dosimetric impact of simulated changes in large bowel content during proton therapy with simultaneous integrated boost for locally advanced pancreatic cancer;Journal of Applied Clinical Medical Physics;2021-10-02

5. microRNA-based autophagy inhibition as targeted therapy in pancreatic cancer;Biomedicine & Pharmacotherapy;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3